Primary Image

Generic Background Image

Clinical Trial

Deep Clinical and Laboratory Characterization of Neurotrauma Patients Who Have Undergone Rehabilitation

IRB Protocol Number STU00211614


Colin Franz


To better understand neurotrauma outcome variability, we’re studying nerve cells made from patients’ own blood using induced pluripotent stem cell (iPSC) technology. The data found in this study will hopefully allow us to predict rehabilitation outcomes as well as better understand the individual patient factors affecting the recovery process.

Who Can Participate

has suffered neurotrauma and undergone acute inpatient rehabilitation at the Shirley Ryan AbilityLab.


Not Provided

Age Range

over the age of 18

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Focus Group: Care Partners of People with SCI

Researchers at Shirley Ryan AbilityLab are recruiting for an online focus group to learn about the experiences and outcomes of people living with spinal cord injuries, and how they are related to the length and intensity of rehabilitation services across countries. The purpose of the study is to learn how rehabilitation experiences and outcomes are related to rehabilitation length of stay across different countries.

read more
view all

Latest Updates

view all